Udo Henseler, Ph.D., is currently the President and proprietor of Management Services International ("MSI"), a private business initiated in 1994.
provides business development services for biotechnology, life sciences and other industrial firms at various stages of their corporate evolution.
has over forty years of combined global public and private company financial and operations leadership experiences mainly in the biopharmaceutical and life sciences sectors.
responsibilities encompassed positions as Director, Board Chairman, Chief Executive Officer, Chief Financial Officer, Executive Vice President, and memberships and/or Chairman of Audit, Compensation and Governance Board committees.
also taught at the now Peter F. Drucker and Masatoshi Ito Graduate School of Management
, Claremont Graduate University
Dr. Henseler earned a B.A. in Germany, an M.B.A. from Fairleigh Dickinson University in New Jersey, and Masters and Ph.D. degrees from the Claremont Graduate University in Claremont, California.
also holds professional designations, in good standing, of Certified Public Accountant, Certified Management Accountant and Chartered Global Management Accountant.
He served as Director and member of the Audit Committee of RTI Biologics, Inc. (formerly Regeneration Technologies, Inc.) through May 2011.
Prior to it being acquired by RTI Biologics, Inc. in February 2008, Dr. Henseler served as a Director and Chairman of the Audit Committee of Tutogen Medical, Inc.
brings broad and key financial, operations, strategic planning, business development, merger and acquisition and international experiences to the Company.
prior career responsibilities, across a range of public and private companies, as director; chairman of board of directors; audit, compensation and governance committee memberships and/or chairman; chief executive officer, chief financial officer and executive vice president, impart essential expertise to the Board of Directors of the Company.
The Company's Board of Directors has determined that Dr. Udo Henseler, member of the Audit Committee, is an "audit committee financial expert" within the meaning of applicable regulations of the Securities and Exchange Commission, based on Dr. Henseler's business experience, as described in his biography.
In 2013, the Compensation Committee was composed of Dr. Magliochetti (chairman), Dr. Henseler and Mr. Redmond.